Format

Send to

Choose Destination
Hepatogastroenterology. 1999 Jul-Aug;46(28):2321-8.

The role of surgery in the treatment of liver metastases for colorectal cancer patients.

Author information

1
Department of Surgery, Technische Universit√§t M√ľnchen, Germany.

Abstract

BACKGROUND/AIMS:

Liver metastases deriving from colorectal cancer can be treated with curative intention in a select number of patients. Controversy does, however, persist pertaining to the impact of adjuvant treatment strategies. The aim of this study is to elucidate upon the various treatment modalities for patients suffering from liver metastases of colorectal primary tumor as well as to provide a rationale for surgical and adjuvant treatment.

METHODOLOGY:

From November 1987 to September 1998, a total of 449 consecutive patients suffering from liver metastases deriving from a colorectal cancer were documented at our institution in a prolective study. Prognostic factors providing the most beneficial outcome (whether with surgical and/or adjuvant treatment modalities) were analyzed by univariate and multivariate analysis.

RESULTS:

Whenever possible, curative (R0) surgical resection of colorectal liver metastases provides the most benefit to the patient. Multivariate analysis revealed tumor infiltration of the lymph nodes of the hepatoduodenal ligament and metachronous occurrence of liver metastases as most independent factors related to survival.

CONCLUSIONS:

Adjuvant post-operative chemotherapy fails to significantly improve survival following resection of liver metastases when compared to the liver resection only group. In patients with unresectable metastases, regional arterial chemotherapy did not improve survival significantly when compared with systemic chemotherapy.

PMID:
10521990
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center